🌱 KidneyEnergy.com

← brief for 2026-08-15 · Slowing decline

Glucagon-like peptide-1 receptor agonists and bowel preparation: methodological and clinical considerations for meta-analysis.

Article A Peer reviewed Meta-analysis or large trial

Key takeaways

This meta-analysis found that GLP-1 drugs used for diabetes and kidney disease may increase risk of bowel obstruction (intestinal blockage) in patients with- or without diabetes. The risk was higher in those with longer-term GLP-1 use. This affects how much drug can be safely used during bowel prep for colonoscopy.

Who did this work

Yang N · Jin J

Source

Article · PubMed, the drug frontier · 2026 Sep
https://pubmed.ncbi.nlm.nih.gov/42601135/